Thursday, Jan 30, 2025 · SEC filings

What the smart money revealed on Jan 30

Real insider buys35insiders · $111M
Real insider sales48insiders · $35.1M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

441 insider filings came in. We hid 41 planned (10b5-1) sellers and 298 people whose filings were routine, like grants and tax withholding.

group

9 insiders at Smithfield Foods (SFD) bought $65.6M of stock

Roles: CEO, President, CFO, Chief Business Officer, Chief Legal Officer, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 29
$65.6M
group

7 insiders at MSC Income Fund (MSIF) bought $1.73M of stock

Roles: CEO, President, CFO, COO, General Counsel, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Jan 30
$1.73M
trending_up

TKO Group (TKO) CEO Ariel Emanuel bought $40.7M

258,576 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 4 beat Traded Jan 28–30
$40.7M
trending_up

Adobe (ADBE) Director David Ricks bought $999K

2,250 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 28
$999K
trending_up

General Motors (GM) Director Alfred Kelly Jr. bought $608K

12,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 30
$608K
trending_up

Mobivity (MFON) Director Thomas Akin bought $466K

1.95M shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Sep 30–Dec 31
$466K
trending_down

3M (MMM) Chairman of the Board Michael Roman sold $7.55M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 180,895 shares directly.

Real sale Form 4 Traded Jan 29
$7.55M
trending_down

Alaska Air Group (ALK) EVP and CCO Andrew Harrison sold $6.53M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 20,638 shares directly.

Real sale Form 4 Traded Jan 28
$6.53M
trending_down

Abbott Laboratories (ABT) Executive Vice President Louis Morrone sold $337K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jan 28
$337K
Show 15 more real buys
Show 45 more real sales
AXP American Express · Grp. Pres. Raymond Joabar · Traded Jan 28
$4.77M
GS Goldman Sachs Group · Chief Risk Officer Alex Golten · Traded Jan 28
$3.31M
DXCM Dexcom · Chairman Kevin Sayer · Traded Jan 29
$2.9M
KBH Kb Home · EVP and CFO Jeff Kaminski · Traded Jan 28
$1.89M
SSII SS Innovations International · Chairman and CEO Sudhir Srivastava · Traded Jan 29
$1.5M
SLM SLM · Director Robert Strong · Traded Jan 28
$1.14M
CUBI Customers Bancorp · Pres Mortgage WarehouseLending Glenn Hedde · Traded Jan 30
$921K
VZ Verizon Communications · EVP and Group CEO-VZ Business Kyle Malady · Traded Jan 28
$810K
ARLO Arlo Technologies · CEO Matthew McRae · Traded Jan 29
$546K
KMX CarMax · SVP and Chief Product Officer Tyler Tuite · Traded Jan 28
$412K
RLAY Relay Therapeutics · President Donald Bergstrom · Traded Jan 28–30
$362K
RLAY Relay Therapeutics · Chief Legal Officer Brian Adams · Traded Jan 28–30
$248K
DXCM Dexcom · EVP Jacob Leach · Traded Jan 29
$229K
RLAY Relay Therapeutics · Officer Peter Rahmer · Traded Jan 28–30
$205K
DXCM Dexcom · EVP Sadie Stern · Traded Jan 29
$182K
DXCM Dexcom · EVP Jereme Sylvain · Traded Jan 29
$182K
ARLO Arlo Technologies · General Counsel Brian Busse · Traded Jan 29
$105K
DXCM Dexcom · EVP Matthew Dolan · Traded Jan 29
$103K
RBCAA Republic Bancorp · Director David Feaster · Traded Jan 29
$93.4K
SNV Synovus Financial · EVP Thomas Dierdorff · Traded Jan 28
$92.5K
APLS Apellis Pharmaceuticals · CEO Cedric Francois · Traded Jan 29
$83.4K
NRIX Nurix Therapeutics · Chief Scientific Officer Gwenn Hansen · Traded Jan 30
$73.3K
NRIX Nurix Therapeutics · Chief Legal Officer Christine Ring · Traded Jan 30
$63.9K
CVLG Covenant Logistics Group · Chief Accounting Officer Matisse Long · Traded Jan 28
$61.2K
NRIX Nurix Therapeutics · CFO Hans van Houte · Traded Jan 30
$55.8K
NWBI Northwest Bancshares · Director Timothy Fannin · Traded Jan 28
$45.6K
IOSP Innospec · SVP Corbin Barnes · Traded Nov 18
$36.1K
APLS Apellis Pharmaceuticals · Chief Scientific Officer Pascal Deschatelets · Traded Jan 29
$24.4K
APLS Apellis Pharmaceuticals · Chief Technical Officer Nur Nicholson · Traded Jan 29
$24.4K
APLS Apellis Pharmaceuticals · Chief Commercial Officer Adam Townsend · Traded Jan 29
$20.5K
APLS Apellis Pharmaceuticals · General Counsel David Watson · Traded Jan 29
$20.5K
IOSP Innospec · SVP Hardy Griffin III · Traded Nov 18
$18.9K
NIC Nicolet Bankshares · Director Robert Atwell · Traded Jan 29
$16.5K
APLS Apellis Pharmaceuticals · CFO Timothy Sullivan · Traded Jan 29
$16.1K
EQBK Equity Bancshares · COO and EVP Julie Huber · Traded Jan 28
$12.2K
CXM Sprinklr · Director Ragy Thomas · Traded Jan 29
$11.7K
APLS Apellis Pharmaceuticals · Chief Business and Strat Officer Mark DeLong · Traded Jan 29
$10.8K
CDLX Cardlytics · Chief Legal and Privacy Officer Nicholas Lynton · Traded Jan 30
$10.8K
APLS Apellis Pharmaceuticals · Chief People Officer Karen Lewis · Traded Jan 29
$10.7K
EQBK Equity Bancshares · General Counsel Brett Reber · Traded Jan 28
$8.86K
APLS Apellis Pharmaceuticals · Chief Development Officer Jeffrey Eisele · Traded Jan 29
$8.21K
EQBK Equity Bancshares · Chief Credit Officer Krzysztof Slupkowski · Traded Jan 28–29
$5.82K
PSNL Personalis · CFO and COO Aaron Tachibana · Traded Jan 28
$4.1K
PSNL Personalis · Chief Medical Officer and EVP Richard Chen · Traded Jan 28
$3.01K
CBUS Cibus · Director Gerhard Prante · Traded Jan 29
$2.78K

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 24–30

Open-market buys by officers and directors, filed in the 7 days up to Jan 30.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist